Piscataway, NJ, January 19, 2022–Camber Pharmaceuticals is pleased to announce the addition of Colchicine Tablets to their current portfolio.
Colchicine Tablets are an alkaloid indicated for Prophylaxis and treatment of gout flares in adults and Familial Mediterranean fever (FMF) in adults and children 4 years or older.
Camber Colchicine 0.6 mg Tablets are available in 30 and 100 count bottles.
To find out more about Colchicine Tablets please visit https://www.camberpharma.com
Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products. Its parent company, Hetero Drugs of Hyderabad India, is one of the world’s leading API and finished dosage manufacturers. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected].
- Camber Pharmaceuticals Launches Generic Pepcid®
- Camber Pharmaceuticals Launches Generic Wellbutrin SR®
- Camber Pharmaceuticals Launches Generic Inspra®
- Camber Pharmaceuticals Launches Generic Prezista®
- Camber Pharmaceuticals Launches Generic Neurontin Caps®
- Camber Pharmaceuticals Launches Generic Zyprexa®